Advertisement

Topics

D-TARGET SA Company Profile

13:13 EDT 24th September 2018 | BioPortfolio

Stratigically located in Switzerland, the heart of Europe, D-TARGET is the number one clinical research organisation specializing in Clinical and Regulatory Services throughout the European continent.
Medical device manufacturers worldwide rely upon D-TARGET's highly trained, multi-lingual professionals for result-oriented solutions in bringing their products to life in more than 25 European countries

Location

En Chamard 55C
Montagny
près-Yverdon
1442
Switzerland

Contact

Email: webmaster@d-target.com


News Articles [67 Associated News Articles listed on BioPortfolio]

Researchers reveal complexity of NMDA receptor drug discovery target

Know your target. Especially if your target is coming into focus for treating diseases such as schizophrenia and treatment-resistant depression.

Performance on A&E target slips further

NHS hospital performance against the four-hour A&E target stood at just 74.96 percent, well under the 95 percent target, for the week ending March 11th, show the most recent data from the Royal Co...

AACR18: Day 1 Cancer & Immunology Symposium

We often talk about ‘on-target off-target’ side effects, but what about the equivalent on-site off-the-reservation meetings?  I’m a big fan…

UNC Lineberger finds new target for kidney cancer

University of North Carolina (UNC) Lineberger Comprehensive Cancer Center has discovered a new potential therapeutic target for clear cell renal...Read More... The post UNC Lineberger finds new target...

Engineered Anthrax Toxin Variants that Target Cancer

This technology describes the use of novel mutated anthrax protective antigen (PA) protein variants to target tumor cells and tumor vasculature. NIH scientists have engineered two PA variants that se...

New system can identify drugs to target 'undruggable' enzymes critical in many diseases

(Medical Research Council) A new drug discovery system allows scientists to specifically target members of an important family of enzymes, called phosphatases, which were previously considered mostly ...

Treat-to-Target in RA: No Increase in AEs

(MedPage Today) -- Implementation of treat-to-target also slightly lowered resource use

CRISPR-Cas9 Used to Knock Out Genes in Robusta Coffee

Scientists Jean-Christophe Breitler from French Agricultural Research Centre for International Development and colleagues developed a web tool to identify all gRNA target sequences in the robusta coff...

PubMed Articles [726 Associated PubMed Articles listed on BioPortfolio]

A forced-convection gas target for the production of CCH.

A forced-convection gas target for the production of [C]CH on a 13 MeV cyclotron was constructed and tested. A small fan was incorporated into the back of the target, which mixes the target gas duri...

SeedVicious: Analysis of microRNA target and near-target sites.

Here I describe seedVicious, a versatile microRNA target site prediction software that can be easily fitted into annotation pipelines and run over custom datasets. SeedVicious finds microRNA canonical...

Detection of microRNA-Target Interactions by Chimera PCR (ChimP).

MicroRNAs (miRNAs) regulate gene expression by directing Argonaute proteins to target RNAs, which usually results in destabilization and translational inhibition of the target RNA. The prediction of a...

Substantial heterogeneity in progress towards reaching the 90-90-90 HIV target in the WHO European Region.

Achieving the UNAIDS 90-90-90 target by 2020 is expected to end the HIV epidemic by 2030. We report on progress in the WHO European Region in meeting this target.

Inferotemporal cortex multiplexes behaviorally-relevant target match signals and visual representations in a manner that minimizes their interference.

Finding a sought visual target object requires combining visual information about a scene with a remembered representation of the target to create a "target match" signal that indicates when a target ...

Clinical Trials [1672 Associated Clinical Trials listed on BioPortfolio]

Preliminary Investigation of optimaL Oxygen Targets Trial

Mechanical ventilation of ICU patients universally involves titration of the fraction of inspired oxygen (FiO2) to maintain arterial oxygen saturation (SpO2). Despite decades of ICU practi...

Treat Stroke to Target

The aim of this study is the evaluation of two usual care strategies after stroke or TIA : achieved target LDL-C of 100 mg/dL (+/-10 mg/dL) or less than 70 mg/dL. Investigators will use th...

Reduction of Remifentanil-related Complications by Limiting Maximum Plasma Concentration During Target-controlled Infusion

This study is intended to evaluate the effect of decreasing the maximum plasma concentration target of remifentanil of the Target Controlled Infusion system on the the incidence of major a...

BP-TARGET : Blood Pressure Target in Acute Stroke to Reduce hemorrhaGe After Endovascular Therapy

A randomized, multicenter study comparing two strategies: 1 / standard management of systolic blood pressure according to international recommendations (systolic blood pressure

Evaluation of the Efficacy of Rosuvastatin in Daily Practice (TARGET)

In this study the effect of the switch to rosuvastatin from another statin (fluvastatin, pravastatin, simvastatin, atorvastatin) was evaluated in high-risk patients with and without eviden...

Companies [611 Associated Companies listed on BioPortfolio]

Target Health Inc. & LifeOnKey Inc.

Target Health, (www.targethealth.com) established in 1993, is a full service eCRO with full-time staff dedicated to all aspects of drug and device development. Areas of exp...

Target Corp.

Minneapolis-based Target Corporation (NYSE:TGT) serves guests at 1,764 stores across the United States and at Target.com. The company plans to open its first stores in Canada in 2...

Target Corporation

Minneapolis-based Target Corporation (NYSE: TGT) serves guests at 1,699 stores in 49 states nationwide and at Target.com. Target is committed to providing a fun and convenient shopping experience with...

Target BioScience AG

Target BioScience AG is a consulting firm focused exclusively on the pharmaceutical and biotechnology fields. Our trademark is our highly practical approach. Target BioScience AG was originally founde...

D-TARGET SA

Stratigically located in Switzerland, the heart of Europe, D-TARGET is the number one clinical research organisation specializing in Clinical and Regulatory Services throughout the European continent....

More Information about "D-TARGET SA" on BioPortfolio

We have published hundreds of D-TARGET SA news stories on BioPortfolio along with dozens of D-TARGET SA Clinical Trials and PubMed Articles about D-TARGET SA for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of D-TARGET SA Companies in our database. You can also find out about relevant D-TARGET SA Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...


Corporate Database Quicklinks



Searches Linking to this Company Record